BRIGHT FUTURE SKIN TINT SPF 25 44 PRALINE- octinoxate, titanium dioxide cream
Bright future skin tint SPF 25 44 Praline by
Drug Labeling and Warnings
Bright future skin tint SPF 25 44 Praline by is a Otc medication manufactured, distributed, or labeled by S+. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
- Drug Facts
- Active ingredient
- Uses
- Warnings
-
Directions
- Apply liberally 15 minutes before sun exposure
- Reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
- Limit time in the sun, especially from 10 a.m. -2 p.m.
- Wear long-sleeved shirts, pants, hats, and sunglasses
- Children under 6 months of age: Ask a doctor
- Other information
-
Inactive ingredients
WATER (AQUA), CYCLOPENTASILOXANE, GLYCERIN, ISODODECANE, PENTYLENE GLYCOL, ALCOHOL, DIMETHICONE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, PEG-10 DIMETHICONE, XANTHAN GUM, SORBITAN SESQUIOLEATE, DISTEARDIMONIUM HECTORITE, PHENOXYETHANOL, ACRYLATES/DIMETHICONE COPOLYMER, ALUMINUM HYDROXIDE, ISOSTEARIC ACID, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, BUTYLENE GLYCOL, POLYHYDROXYSTEARIC ACID, SODIUM MYRISTOYL GLUTAMATE, SILICA SILYLATE, PROPYLENE CARBONATE, STEARIC ACID, HYDROLYZED RICE PROTEIN, SODIUM METABISULFITE, BHT, SHEA (BUTYROSPERMUM PARKII) SEEDCAKE EXTRACT, LEMON (CITRUS LIMON) FRUIT EXTRACT, TOCOPHEROL, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77492), IRON OXIDES (CI 77491), IRON OXIDES (CI 77499).
- Package Labeling:
- Inner Label
-
INGREDIENTS AND APPEARANCE
BRIGHT FUTURE SKIN TINT SPF 25 44 PRALINE
octinoxate, titanium dioxide creamProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC: 31720-710 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE 74.9 mg in 1 mL TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 22.8 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) CYCLOMETHICONE 5 (UNII: 0THT5PCI0R) GLYCERIN (UNII: PDC6A3C0OX) ISODODECANE (UNII: A8289P68Y2) PENTYLENE GLYCOL (UNII: 50C1307PZG) ALCOHOL (UNII: 3K9958V90M) DIMETHICONE (UNII: 92RU3N3Y1O) VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER (UNII: 9NH1UDD2RR) PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0) XANTHAN GUM (UNII: TTV12P4NEE) SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A) DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L) PHENOXYETHANOL (UNII: HIE492ZZ3T) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) ISOSTEARIC ACID (UNII: X33R8U0062) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) SODIUM MYRISTOYL GLUTAMATE (UNII: AYU7QD893W) PROPYLENE CARBONATE (UNII: 8D08K3S51E) STEARIC ACID (UNII: 4ELV7Z65AP) SODIUM METABISULFITE (UNII: 4VON5FNS3C) BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) TOCOPHEROL (UNII: R0ZB2556P8) FERRIC OXIDE YELLOW (UNII: EX438O2MRT) FERRIC OXIDE RED (UNII: 1K09F3G675) FERROSOFERRIC OXIDE (UNII: XM0M87F357) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC: 31720-710-17 1 in 1 CARTON 08/28/2017 1 25 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part352 08/28/2017 Labeler - S+ (572406531)
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.